Searching for a therapy of creatine transporter deficiency: Some effects of creatine ethyl ester in brain slices in vitro

Neuroscience

Volumn 199, Issue , 2011, Pages 386-393

  Adriano, E ^a   Garbati, P ^a   Damonte, G ^a   Salis, A ^a   Armirotti, A ^a,b   Balestrino, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Anoxia; Creatine; Creatine ethyl ester; Creatine transporter deficiency; Hippocampal slices; Neuroprotection

Indexed keywords

AMINO ACID DERIVATIVE; CREATININE ETHYL ESTER; UNCLASSIFIED DRUG;

AMINO ACID DEFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE TRANSPORTER DEFICIENCY; DRUG EFFICACY; DRUG MECHANISM; EVOKED RESPONSE; LIPOPHILICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATINE; HIPPOCAMPUS; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED ICR; ORGAN CULTURE TECHNIQUES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 83055186656     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.09.018     Document Type: Article

References (24)

1. Andersen P., Bliss T.V., Skrede K.K. Unit analysis of hippocampal population spikes. Exp Brain Res 1971, 13:208-221.
2. Balestrino M., Rebaudo R., Lunardi G. Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship. Brain Res 1999, 816:124-130.
3. Ballanyi K. In vitro preparations. Modern techniques in neuroscience research 1999, 307-326. Springer-Verlag, Heidelberg, Germany. U. Windhorst, H. Johansson (Eds.).
4. Dai W., Vinnakota S., Qian X., Kunze D.L., Sarkar H.K. Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes. Arch Biochem Biophys 1999, 361:75-84.
5. Degrauw T.J., Cecil K.M., Byars A.W., Salomons G.S., Ball W.S., Jakobs C. The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem 2003, 244:45-48.
6. Fitch C.D., Sinton D.W. A study of creatine metabolism in diseases causing muscle wasting. J Clin Invest 1964, 43:444-452.
7. Fons C., Arias A., Sempere A., Pòo P., Pineda M., Mas A., Lòpez-Sala A., Garcia-Villoria J., Vilaseca M.A., Ozaez L., Lluch M., Artuch R., Campistol J., Ribes A. Response to creatine analogs in fibroblasts and patients with creatine transporter deficiency. Mol Genet Metab 2010, 99:296-299.
8. Giese M.W., Lecher C.S. Non-enzymatic cyclization of creatine ethyl ester to creatinine. Biochem Biophys Res Commun 2009, 388:252-255.
9. Katseres N.S., Reading D.W., Shayya L., DiCesare J.C., Purser G.H. Non-enzymatic hydrolysis of creatine ethyl ester. Biochem Biophys Res Commun 2009, 386:363-367.
10. La Du B. Plasma esterase activity and the metabolism of drugs with ester groups. Ann N Y Acad Sci 1971, 179:684-694.
11. Lunardi G., Parodi A., Perasso L., Pohvozcheva A.V., Scarrone S., Adriano E., Florio T., Gandolfo C., Cupello A., Burov S.V., Balestrino M. The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds. Neuroscience 2006, 142:991-997.
12. Perasso L., Cupello A., Lunardi G.L., Principato C., Gandolfo C., Balestrino M. Kinetics of creatine in blood and brain after intraperitoneal injection in the rat. Brain Res 2003, 974:37-42.
13. Perasso L., Lunardi G., Risso F., Pohvozcheva A., Leko M., Gandolfo C., Florio T., Cupello A., Burov S., Balestrino M. Protective effects of some creatine derivatives in brain tissue anoxia. Neurochem Res 2008, 33:765-775.
14. Persky A.M., Brazeau G.A. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 2001, 53:161-176.
15. Ravera S, Adriano E, Balestrino M, Panfoli I (in press) Creatine ethyl ester: a new substrate for creatine kinase. Molecular biology (English translation from Molekularnaya Biologiya), in press.
16. Salomons G., Van Dooren S., Verhoeven N., Marsden D., Schwartz C., Cecil K., DeGrauw T., Jakobs C. X-linked creatine transporter defect: an overview. J Inherit Metab Dis 2003, 26:309-318.
17. Salomons G.S., van Dooren S.J., Verhoeven N.M., Cecil K.M., Ball W.S., Degrauw T.J., Jakobs C. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 2001, 68:1497-1500.
18. Schedel J.M., Tanaka H., Kiyonaga A., Shindo M., Schutz Y. Acute creatine ingestion in human: consequences on serum creatine and creatinine concentrations. Life Sci 1999, 65:2463-2470.
19. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. analytical biochemistry 1985, 150(1):76-85.
20. Spillane M., Schoch R., Cooke M., Harvey T., Greenwood M., Kreider R., Willoughby D.S. The effects of creatine ethyl ester supplementation combined with heavy resistance training on body composition, muscle performance, and serum and muscle creatine levels. J Int Soc Sports Nutr 2009, 6:6.
21. Velema M.S., de Ronde W. Elevated plasma creatinine due to creatine ethyl ester use. Neth J Med 2011, 69:79-81.
22. Vennerstrom J.L., Miller D.W. Creatine ester pronutrient compounds and formulations 2002, Patent number WO0222135, USA.
23. Walzel B., Speers O., Zanolla E., Eriksson O., Bernardi P., Wallimann T. Novel mitochondrial creatine transport activity. Implications for intracellular creatine compartments and bioenergetics. J Biol Chem 2002, 277:37503-37511.
24. Whittingham T.S., Lipton P. Cerebral synaptic transmission during anoxia is protected by creatine. J Neurochem 1981, 37:1618-1621.